Abstract B236: Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines harboringFGFR2amplification, which is a potential therapeutic target in gastric cancer.
2014 ◽
Vol 13
(11)
◽
pp. 2527-2536
◽
Keyword(s):
Keyword(s):
1995 ◽
Vol 60
(4)
◽
pp. 238-241
◽
2016 ◽
Keyword(s):
2011 ◽
Vol 30
(4)
◽
pp. 1352-1360
◽
Keyword(s):
2006 ◽
Vol 17
(4)
◽
pp. 445-453
◽